Navigation Links
Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer

NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated and Bristol-Myers Squibb Company today announced results from an open-label Phase III study of ERBITUX(R) (Cetuximab) plus a taxane and carboplatin in the first-line treatment for metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of progression-free survival (PFS) as assessed by an independent radiology review committee (IRRC). However, key secondary endpoints of the study, including response rate as assessed by the IRRC and PFS as assessed by clinical investigators, were statistically significant and favored the ERBITUX- containing arm.

Known as BMS CA225-099, this study included more than 600 patients from the United States and Canada and was one of several clinical trials intended to establish the role of ERBITUX in the treatment of advanced NSCLC. Data from the largest of these trials, an ongoing multinational Phase III study of ERBITUX plus cisplatin and vinorelbine intended to be the pivotal study for the ERBITUX NSCLC regulatory strategy, are not yet available.

"We consider lung cancer to be a high priority and await the results of other Phase II and Phase III evaluations of ERBITUX in the first- and second- line setting with chemotherapy regimens," stated Eric K. Rowinsky, M.D., Chief Medical Officer and Senior Vice President of ImClone Systems.

"Lung cancer is a devastating disease with few effective treatment options," said Martin Birkhofer, M.D., Vice President, Oncology Global Medical Affairs, Bristol-Myers Squibb. "Efforts to fully interpret these results are ongoing, and the companies plan to submit the data from this study to an upcoming medical meeting in 2007."

About Lung Cancer

The American Cancer Society estimates that in the U.S., more than 213,000 people will be diagnosed with lung cancer in 2007. Lung cancer is the leading cause of cance
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
2. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
3. Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
4. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
5. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:4/24/2015)... , April 24, 2015  Elekta has CE marked ... treatment planning system , enabling European clinics to deliver ... treatment techniques including advanced 3D planning, IMRT, VMAT and ... Monaco ® ... improved workflow efficiency. Advancements in 3D planning as well ...
(Date:4/23/2015)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... hemodynamic monitoring, today reported net income for the quarter ... diluted share.  Net income for the same period a ... share, and non-GAAP net income was $82.1 million, or ... the quarter ended March 31, 2015 increased 13.0 percent to ...
(Date:4/23/2015)... 23, 2015 /CNW/ - Health Canada is working with ... update the safety information regarding the risk of serious ... these products are used at high doses (at or ... duration of use. Ibuprofen is a non-steroidal ... and to reduce inflammation. The majority of ibuprofen products ...
Breaking Medicine Technology:Elekta CE marks for Monaco v5.10 treatment planning system 2Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4
... 2011 Texas Institute of Dermatology, Laser and Cosmetics is ... including San Antonio and Boerne area to treat superficial vascular ... "I,m very excited to add this new service for our ... Laser and Cosmetics. "As a long time provider of aesthetic ...
... SAN DIEGO, Feb. 1, 2011 CareFusion Corporation ... announced today the appointment of Kieran T. Gallahue as chairman ... announced plans to retire later this month. A ... and CEO of ResMed (NYSE: RMD ), a ...
Cached Medicine Technology:San Antonio's Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients 2CareFusion Names Kieran T. Gallahue Chairman and CEO 2CareFusion Names Kieran T. Gallahue Chairman and CEO 3
(Date:4/24/2015)... 2015 Anchor Health Administrators (Anchor), specialists ... today announced their exclusive agreement with LTC Solutions for ... Insurance distribution partner. , Anchor has more than 18 ... benefits for associations, and is currently the designated advocate ... Term Care Insurance member benefit. , “I am very ...
(Date:4/24/2015)... 24, 2015 “Kind,” “selfless,” “the voice ... the ways Denise Weiner described pediatric oncology nurse Laura ... her daughter, Alexa, during her five-year battle with a ... bone marrow transplant and numerous experimental treatments, Vasquez continued ... Alexa when she was not in the hospital and ...
(Date:4/24/2015)... ON (PRWEB) April 24, 2015 ... safe, informed and legal access to medical cannabis, is ... are properly supported when advising patients. , NAC is ... Certificate Program. With a $250,000 grant, NAC will be ... program. , "Our goal is to help Canadians gain ...
(Date:4/24/2015)... MMJ Physician Practice in Salem, ... to enroll in the Massachusetts medical marijuana program.    Their ... away from Alternative Therapies Group (ATG), the first ... summer. With the dispensary nearby, MMJ Physician ... for residents of eastern Massachusetts to enroll in ...
(Date:4/24/2015)... WA (PRWEB) April 24, 2015 ... health management organizations, has published a new resource ... Improvement Guide.” The guide to Quality and Resource ... for Medicaid & Medicare Services (CMS) to help ... of care, streamline resources, and identify care coordination ...
Breaking Medicine News(10 mins):Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Medical Doctor from Salem Massachusetts Supports the Medical Marijuana Industry 2Health News:Qualis Health Publishes Guide to Help Physician Practices Assess and Improve Quality 2
... At the request of the presidential transition team, ... package were provided today by the American College of ... physicians and medical student members. It is the ... second largest physician membership organization. , "ACP believes that ...
... Pyramid Developers, a leader in the planning and development ... joined with Scottsdale based Dr. Theresa Ramsey,s Center For Natural ... Of the People" reflecting the focus of the collaboration - ... wellness focused sustainable communities. , , ...
... consistently outperform women on spatial tasks, including mental rotation, ... object would appear if rotated in space. Now, a ... sex-linked ability and the structure of the parietal lobe, ... , The parietal lobe was already known to differ ...
... , BETHESDA, Md., Dec. 17 ... the Cystic Fibrosis Foundation, today announced its 20th anniversary of ... nationwide. , , The organization ... a mission to improve access to specialty medications for people ...
... wake of the historic economic crisis and just days before ... and other thought leaders will gather at the University ... energy demand, health care, the environment and other issues related ... Business Forum, presented by the John S. and James L. ...
... It,s time patient consent forms came back full circle to ... liability they have become. The original purpose of the consent ... patient of common or serious risks associated with the procedure ... written as formal, legal documents plants a litigious ...
Cached Medicine News:Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 2Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 4Health News:Sex difference on spatial skill test linked to brain structure 2Health News:Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary 2Health News:Top CEOs and Other Executives Gather in Miami to Address Economic Crisis, Alternative Energy, Health Care and More 2Health News:Top CEOs and Other Executives Gather in Miami to Address Economic Crisis, Alternative Energy, Health Care and More 3Health News:Patient consent forms should educate not intimidate 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: